BiotechTube
Home/Investors/OrbiMed Asia

OrbiMed Asia

Biotech Investor · 6 portfolio companies

Portfolio
6
Focus Areas
6
Top Stage
phase-1

Investment Focus

MetabolicOncologyGene TherapyCell TherapyInfectious DiseaseImmunology

Portfolio Companies

CompanyValuation
Evive Biotech—
Conjustar—
Biomics Biopharma—
Hepagene Therapeutics—
Immunotech Biopharm—
Kanglin Biotechnology—

Frequent Co-Investors

TF Capital4 sharedSinovation Ventures3 sharedLilly Asia Ventures2 sharedSequoia Capital China1 sharedGL Ventures1 sharedCBC Group1 shared